$JAZZ Jazz Pharmaceuticals plc Insider Trading Week 32/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Jazz Pharmaceuticals plc in week 32/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 133.15 | 1,087 | 144,734 | 14,150 | 15.2 K to 14.2 K (-7.13 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 133.15 | 1,731 | 230,483 | 5,529 | 7.3 K to 5.5 K (-23.84 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 133.15 | 1,087 | 144,734 | 3,993 | 5.1 K to 4 K (-21.40 %) |
Aug 14 2014 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 133.15 | 1,087 | 144,734 | 3,993 | 5.1 K to 4 K (-21.40 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 133.86 | 1,956 | 261,830 | 21,713 | 23.7 K to 21.7 K (-8.26 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 59.13 | 2,372 | 140,256 | 17,187 | |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | M | 46.83 | 2,561 | 119,932 | 30,019 | |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Sell | S | 135.42 | 4,933 | 668,027 | 42,538 | 47.5 K to 42.5 K (-10.39 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 59.13 | 2,372 | 140,256 | 47,471 | 45.1 K to 47.5 K (+5.26 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Buy | M | 46.83 | 2,561 | 119,932 | 45,099 | 42.5 K to 45.1 K (+6.02 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Payment of Exercise | F | 133.86 | 4,565 | 611,071 | 42,538 | 47.1 K to 42.5 K (-9.69 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Payment of Exercise | F | 133.86 | 2,729 | 365,304 | 24,824 | 27.6 K to 24.8 K (-9.90 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Sell | S | 133.15 | 1,185 | 157,783 | 51,804 | 53 K to 51.8 K (-2.24 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Payment of Exercise | F | 133.86 | 4,565 | 611,071 | 52,989 | 57.6 K to 53 K (-7.93 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 133.15 | 5,000 | 665,750 | 579,023 | 584 K to 579 K (-0.86 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Payment of Exercise | F | 133.86 | 13,044 | 1,746,070 | 584,023 | 597.1 K to 584 K (-2.18 %) |
Aug 13 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Payment of Exercise | F | 133.86 | 4,473 | 598,756 | 60,059 | 64.5 K to 60.1 K (-6.93 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,650 | 0 | 15,237 | 13.6 K to 15.2 K (+12.14 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 135.44 | 5,000 | 677,200 | 5,000 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,650 | 0 | 7,260 | 5.6 K to 7.3 K (+29.41 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,650 | 0 | 5,006 | 3.4 K to 5 K (+49.17 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,650 | 0 | 6,150 | 4.5 K to 6.2 K (+36.67 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,650 | 0 | 1,407,205 | 1.4 M to 1.4 M (+0.12 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,650 | 0 | 5,650 | 4 K to 5.7 K (+41.25 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,650 | 0 | 5,650 | 4 K to 5.7 K (+41.25 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,650 | 0 | 5,080 | 3.4 K to 5.1 K (+48.10 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 135.44 | 3,300 | 446,952 | 3,300 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,650 | 0 | 5,080 | 3.4 K to 5.1 K (+48.10 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Option Exercise | A | 135.44 | 15,000 | 2,031,600 | 15,000 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Operati ... | Grant | A | 0.00 | 7,500 | 0 | 64,532 | 57 K to 64.5 K (+13.15 %) |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 135.44 | 20,000 | 2,708,800 | 20,000 | |
Aug 11 2014 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |